BPRx 060234

Drug Profile

BPRx 060234

Alternative Names: BPRx-060234

Latest Information Update: 10 Aug 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Biotica Pharmaceuticals
  • Class Cannabinoids
  • Mechanism of Action Amyloid modulators; Tau protein modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Research Alzheimer's disease

Most Recent Events

  • 03 Aug 2016 Early research in Alzheimer's disease in USA (unspecified route)
  • 03 Aug 2016 Biotica files for patent protection for BPRx™ technology (Biotica website, August 2016) before August 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top